news
WHO advises against obesity drugs for kids under 10
The World Health Organization (WHO) is recommending against weight-loss medications for children under 10 with obesity. Instead, they're pushing for structured interventions focusing on diet, physical activity, and behavior, especially for childhood and adolescent obesity. This moves the conversation beyond just pharmaceutical solutions.
The World Health Organization (WHO) is recommending against weight-loss medications for children under 10 with obesity. Instead, they're pushing for structured interventions focusing on diet, physical activity, and behavior, especially for childhood and adolescent obesity. This moves the conversation beyond just pharmaceutical solutions.
The architecture take
The WHO's take on childhood obesity feels like a necessary reality check. We're in an era where GLP-1s are seen as a miracle, but for kids under 10, the conversation should absolutely center on the basics: how they eat, how they move, and the patterns they're learning. Pharmaceuticals come with their own set of metabolic and nervous-system unknowns, especially in a developing body. Framing it as 'beyond drugs' doesn't diminish the severity of obesity, but it pushes back on the easy fix. My read? This is less about shaming pharma and more about reminding parents and practitioners that complex metabolic challenges—like insulin sensitivity and satiety signaling—start with environment, not just a prescription. It's a call to action for public health and family systems, not just the pharmacy.